Agenda

  1. Coffee and registration

  2.  

    Chair:

    David Dillon David Dillon
    Independent Biocides Expert
  3. Session 1: Updates from the authorities
  4. Update from the commission: Latest developments in the biocides field

    • Active substances
    • Product authorisation
    • Endocrine disruptors
    • Treated articles
    • Implementation & enforcement
    Alfonso Las Heras Alfonso Las Heras
    Policy Officer, DG Sante, EU Commission
  5. ECHA’s latest updates

    • Review programme progress
    • Union authorisations
    • Regulatory IT developments
    • Dissemination
    • Support to industry
    Valerio Spinosi Valerio Spinosi
    Scientific and Regulatory Officer, ECHA
  6. Q&A

  7. Refreshments

  8. Session 2: Risk Assessment
  9. Environmental Risk Assessment of disinfectants – new aspects and developments

    • Environmental risk assessment of disinfectant products
    • Emission Scenarios for disinfectants
    • Challenges and ways forward
    Susanne Hardt Susanne Hardt
    Dr Knoell
  10. The new ECHA guidance for disinfection by-products

    • Background on the disinfection by-products formation
    • Product types relevant for the risk assessment
    • Approach to the Human Health Risk Assessment
    • Approach to the Environmental Risk Assessment
  11. Estimating consumer exposure via biocide residues in food

    • Domestic use of disinfectants and insecticides
    • ECHA Guidance on non-professional uses
    • Models for estimating consumer exposure
    Kathrin Gottlob Kathrin Gottlob
    Scientific Officer, Federal Institute for Risk Assessment (BfR)
  12. Q&A session

  13. Human Health Risk Assessment; an overview of exposure modelling

    • What is exposure modelling
    • Why is it needed
    • Summary of available guidance
    • Overview of available models and their usefulness
    • What to do if there is no model
    Sara Kirkham Sara Kirkham
    Director, Arrow Regulatory Ltd
  14. Human Health Risk Assessment for in-situ products

    • Basics of in-situ products and assessments
    • Data requirements for human health
    • Models and tools for estimating human exposure
    • Tips, tricks and pitfalls
    Silvia Wagner Silvia Wagner
    Managing Director, spectra Consult, Germany
  15. Q&A

  16. Lunch

  17. Session 3: Efficacy
  18. Update on the ECHA Efficacy Working Group

    • Guidance
    • Active substance
    • Union authorisation
    • MR referrals
    Valerio Spinosi Valerio Spinosi
    Scientific and Regulatory Officer, ECHA
  19. Repellents' and attractants' efficacy – Lessons learned and new challenges

    • Link between efficacy and mode of action of active substances
    • PT 19 in new efficacy guidance
    • Common problems in testing design 
    • Market needs and efficacy challenges
    Karolina Pastuszko Karolina Pastuszko
    Chief Specialist, The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
  20. Session 4: Brexit and the BPR
  21. Brexit and Biocidal: In search of enhanced predictability

    • Timing and state of play
    • Active substance dossiers under review by HSE
    • Product authorisation issues
    • Article 95 BPR: status of UK-based companies
    • Contractual issues
    • UK participation in international fora
    Koen Van Maldegem Koen Van Maldegem
    Partner, EU Regulatory, Fieldfisher LLP, Belgium
  22. Q&A

  23. Refreshments

  24. Session 5: Borderline issues
  25. Case studies of chemicals regulated under the BPR, PPPR and REACH: what can we learn?

    • Overview of regulatory procedures and regulatory bodies involved
    • Case studies of substances regulated under different legislations
    • Borderline case BPR/PPPR
    An Vanden Bosch An Vanden Bosch
    Senior Project Scientist, ARCHE Consulting
  26. Session 6 - Experiences with Active Substance Approval/Renewal, part I
  27. AS and product renewals – an industry perspective

    • The process
    • Timelines
    • Learning from our experience
    • How to improve the process
    Anne Withall Anne Withall
    Regulatory Manager, PelGar International
  28. Q&A

  29. Session 7 - 20th Anniversary of the Vienna Biocides Conference
  30. Panel Discussion - looking back over the past 20 years of Biocides Regulation and looking forward

    Alfonso Las Heras Alfonso Las Heras
    Policy Officer, DG Sante, EU Commission
    Anne Withall Anne Withall
    Regulatory Manager, PelGar International
    Sara Kirkham Sara Kirkham
    Director, Arrow Regulatory Ltd
    Edmund Plattner Edmund Plattner
    Consultant, former Head of Biocides Division, Ministry of Agriculture, Forestry, Environment and Water Management
    Mary Iakovidou Mary Iakovidou
    EU Co-ordination, KEMI
    Roland Solecki Roland Solecki
    Director, Head of Department Pesticide Safety, Federal Institute for Risk Assessment (BfR)
  31. Close of day one